PBH - NYSE

Prestige Consumer Healthcare Inc.

PBH·NYSE

$45.44

-1.1%

HealthcareMedical - Distribution

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.15B

EPS3.9300

P/E Ratio11.56

Earnings Date08/06/2026

3.49B

Assets

3Y+4.0%

5Y+2.0%

10Y-11.0%

1.61B

Total Liabilities

3Y-16.0%

5Y-22.0%

10Y-48.0%

1.89B

Total Equity

3Y+30.0%

5Y+39.0%

10Y+129.0%

Prestige Consumer Healthcare Inc. Funding & Solvency Profile

PBH · NYSE

Current Assets

Cash & Cash Equivalents63.87M

Net Receivables191.92M

Inventory159.13M

Other Current Assets16.56M

Total Current Assets431 M

Non-Current Assets

Property, Plant & Equipment171.25M

Goodwill & Intangible Assets2.88B

Long-Term Investments0.00

Other Non-Current Assets10.87M

Total Non-Current Assets182 M

Total Assets

3.49B

Financial Health Analysis

Current Ratio

3.57x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.85x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

311 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

12% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Prestige Consumer Healthcare Inc. Balance Sheet

PBH • NYSE

Prestige Consumer Healthcare Inc. Balance Sheet	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008	Mar 2007
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	63.9M	97.9M	46.5M	58.5M	27.2M	32.3M	94.8M	27.5M	32.5M	41.9M	27.2M	21.3M	28.3M	15.7M	19M	13.3M	41.1M	35.2M	6.1M	13.8M
Cash & Short-Term Investments	63.9M	97.9M	46.5M	58.5M	27.2M	32.3M	94.8M	27.5M	32.5M	41.9M	27.2M	21.3M	28.3M	15.7M	19M	13.3M	41.1M	35.2M	6.1M	13.8M
Net Receivables	191.9M	194.3M	176.8M	167M	139.3M	114.7M	150.5M	148.8M	140.9M	136.7M	95.2M	87.9M	65.1M	73.1M	60.2M	44.4M	30.6M	36M	44.2M	35.2M
Accounts Receivables	0.0	185.7M	168.7M	163.2M	139.3M	114.7M	150M	148.1M	140.1M	135.3M	94M	85.5M	63.7M	72.4M	50.9M	44.4M	30.6M	36M	44.2M	35.2M
Other Receivables	0.0	8.6M	8.1M	3.8M	52K	0.0	560K	705K	783K	1.4M	1.3M	2.4M	1.4M	615K	9.4M	0.0	0.0	0.0	0.0	0.0
Inventory	159.1M	147.7M	138.7M	162.1M	120.3M	115M	116M	119.9M	118.5M	115.6M	91.3M	74M	65.6M	60.2M	51.1M	39.8M	29.2M	27M	29.7M	30.2M
Prepaids	0.0	0.0	0.0	0.0	6.4M	7.9M	4.4M	4.7M	11.5M	40.2M	25.2M	10.4M	11.7M	8.9M	11.4M	4.8M	4.9M	1.4M	2.3M	1.9M
Other Current Assets	16.6M	8.4M	13.1M	4.1M	0.0	0.0	0.0	4.7M	0.0	40.2M	10.1M	8.1M	6.5M	6.3M	5.3M	10.1M	11.3M	5.4M	3.1M	2.7M
Total Current Assets	431.5M	448.3M	375M	391.7M	293.3M	269.8M	365.7M	300.9M	303.5M	334.4M	249M	201.7M	177.2M	164.2M	147M	107.6M	112.2M	103.6M	85.4M	83.8M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	171.2M	127.8M	89.3M	89.5M	98.5M	102.8M	90.7M	51.2M	52.6M	50.6M	15.5M	13.7M	9.6M	9.9M	1.3M	1.4M	1.4M	1.4M	1.4M	1.4M
Goodwill	581.1M	527.4M	527.7M	527.6M	579M	578.1M	575.2M	578.6M	620.1M	615.3M	360.2M	290.7M	190.9M	167.5M	173.7M	154.9M	111.5M	114.2M	308.9M	310.9M
Intangible Assets	2.3B	2.3B	2.3B	2.3B	2.7B	2.5B	2.5B	2.5B	2.8B	2.9B	2.3B	2.1B	1.4B	1.4B	1.4B	786.4M	559.2M	577.6M	646.7M	657.2M
Goodwill & Intangible Assets	2.9B	2.8B	2.8B	2.9B	3.3B	3.1B	3.1B	3.1B	3.4B	3.5B	2.7B	2.4B	1.6B	1.5B	1.6B	941.3M	670.7M	691.8M	955.6M	968.1M
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-399.6M	-26K	-715.1M	-10.1M	-8.1M	-6.5M	-6.3M	-5.3M	-5.3M	-6.4M	-4M	-3.1M	-2.7M
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	399.6M	26K	715.1M	10.1M	8.1M	6.5M	6.3M	5.3M	5.3M	6.4M	4M	3.1M	2.7M
Other Non-Current Assets	10.9M	3.3M	5.7M	3M	3.3M	2.9M	3M	3.1M	3.6M	7.5M	1.3M	28.6M	23.2M	24.9M	35.7M	6.6M	7.1M	4.6M	6.8M	10.1M
Total Non-Current Assets	3.1B	3B	2.9B	3B	3.4B	3.2B	3.1B	3.1B	3.5B	3.6B	2.7B	2.5B	1.6B	1.6B	1.6B	949.3M	679.3M	697.8M	963.8M	979.6M
Total Assets	3.5B	3.4B	3.3B	3.4B	3.7B	3.4B	3.5B	3.4B	3.8B	3.9B	2.9B	2.7B	1.8B	1.7B	1.8B	1.1B	791.4M	801.4M	1B	1.1B
LIABILITIES
CURRENT LIABILITIES
Total Payables	0.0	19.8M	41.5M	73.4M	58.4M	50M	67.5M	56.6M	61.4M	70.2M	38.3M	46.1M	48.3M	51.9M	27.3M	21.6M	12.8M	18.7M	20.5M	19.3M
Accounts Payable	22.8M	18.9M	39M	62.7M	55.8M	46M	62.4M	56.6M	61.4M	70.2M	38.3M	46.1M	48.3M	51.4M	26.7M	21.6M	12.8M	18.1M	20.5M	19.3M
Other Payables	0.0	830K	2.6M	10.6M	2.7M	4M	5.1M	0.0	0.0	0.0	0.0	0.0	0.0	493K	577K	0.0	0.0	1.4M	0.0	0.0
Accrued Expenses	0.0	64.1M	12.2M	63.3M	56.3M	49.6M	62.2M	70.3M	59.9M	69M	57.1M	48.6M	33M	8.8M	7.2M	7.6M	5.2M	750K	13.8M	18.1M
Short Term Debt	9.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6M	3.6M	3.6M	3.6M
Capital Lease Obligations (Current)	0.0	8.5M	6.2M	9.8M	9.1M	8.4M	6.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	830K	2.6M	10.6M	2.7M	4M	5.1M	88K	1.9M	22.8M	10M	2.6M	1.9M	493K	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	492K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	111.4M	14.2M	57.1M	14.3M	19.6M	14.1M	13.4M	88K	1.9M	22.8M	11.3M	4.3M	3.1M	36M	29.4M	25M	8.1M	11.2M	0.0	0.0
Total Current Liabilities	120.9M	106.6M	117M	160.7M	143.4M	122.1M	149.9M	127M	123.2M	162M	106.7M	99M	84.4M	96.7M	63.9M	54.2M	55.7M	34.2M	37.9M	40.9M
NON-CURRENT LIABILITIES
Long Term Debt	38.9M	992.4M	1.1B	1.3B	1.5B	1.5B	1.7B	1.8B	2B	2.2B	1.6B	1.6B	934.4M	970.9M	1.1B	486.9M	294.6M	374.8M	407.7M	459.8M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-194.3M	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	447.4M	419.6M	403.6M	380.4M	444.9M	434.1M	407.8M	399.6M	442.5M	715.1M	469.6M	351.6M	213.2M	194.3M	167.7M	153.9M	112.1M	98M	122.1M	114.6M
Other Non-Current Liabilities	999.5M	5.4M	9.2M	8.2M	7.5M	8.6M	25.4M	20.1M	23.3M	18M	2.8M	2.5M	327K	0.0	0.0	0.0	0.0	0.0	2.4M	2.8M
Total Non-Current Liabilities	1.5B	1.5B	1.5B	1.7B	1.9B	1.9B	2.2B	2.2B	2.5B	2.9B	2.1B	1.9B	1.1B	1.2B	1.3B	640.9M	406.7M	472.8M	532.2M	577.2M
Capital Lease Obligations	0.0	51.9M	13.9M	21.3M	29.7M	35M	36.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	1.6B	1.6B	1.7B	1.9B	2.1B	2.1B	2.3B	2.3B	2.6B	3.1B	2.2B	2B	1.2B	1.3B	1.4B	695.1M	462.4M	507M	570.1M	618.1M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	-277.2M	-219.6M	-189.1M	-133.6M	-130.7M	-117.6M	-59.9M	-7.7M	-6.6M	-5.2M	-3.5M	-1.4M	-687K	-687K	-416K	-63K	-63K	-47K	-40K
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	315K	352K	0.0	412K	261K	283K	283K	0.0	0.0	334K	0.0	0.0
Common Stock	0.0	560K	555K	548K	544K	540K	538K	536K	534K	533K	530K	525K	520K	513K	505K	503K	502K	501K	501K	501K
Additional Paid-In Capital	0.0	593.4M	567.4M	535.4M	515.6M	499.5M	488.1M	479.2M	468.8M	458.3M	445.2M	426.6M	414.4M	401.7M	391.9M	387.9M	384M	382.8M	380.4M	379.2M
Retained Earnings	1.7B	1.6B	1.3B	1.1B	1.2B	1B	844.1M	701.8M	736.3M	396.7M	327.3M	227.4M	149.1M	76.2M	10.7M	-26.2M	-55.4M	-87.5M	99.3M	65.3M
Accumulated Other Comprehensive Income/Loss	-28.4M	-37.7M	-34.5M	-31.6M	-19M	-19.8M	-44.2M	-25.7M	-19.3M	-26.4M	-23.5M	-23.4M	739K	-104K	-13K	-2.8M	-2.5M	-1.3M	-999K	313K
Other Total Stockholders' Equity	169.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	1.9B	1.8B	1.7B	1.4B	1.6B	1.4B	1.2B	1.1B	1.2B	822.5M	744.3M	627.6M	563.4M	477.9M	402.7M	361.8M	329.1M	294.4M	479.1M	445.3M
Total Equity	1.9B	1.8B	1.7B	1.4B	1.6B	1.4B	1.2B	1.1B	1.2B	822.5M	744.3M	627.6M	563.4M	477.9M	402.7M	361.8M	329.1M	294.4M	479.1M	445.3M
SUMMARY
Total Liabilities & Equity	3.5B	3.4B	3.3B	3.4B	3.7B	3.4B	3.5B	3.4B	3.8B	3.9B	2.9B	2.7B	1.8B	1.7B	1.8B	1.1B	791.4M	801.4M	1B	1.1B
Total Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-399.6M	-26K	-715.1M	-10.1M	-8.1M	-6.5M	-6.3M	-5.3M	-5.3M	-6.4M	-4M	-3.1M	-2.7M
Total Debt	48.5M	1B	1.1B	1.4B	1.5B	1.5B	1.8B	1.8B	2B	2.2B	1.6B	1.6B	934.4M	970.9M	1.1B	486.9M	324.1M	378.3M	411.2M	463.4M
Net Debt	-15.4M	946.4M	1.1B	1.3B	1.5B	1.5B	1.7B	1.8B	2B	2.2B	1.6B	1.6B	906.1M	955.2M	1.1B	473.6M	283M	343.2M	405.1M	449.6M
Shares Outstanding	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116	49,438,116

SEC Filings

PBH - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-K 10-K 2026 FY FY	May 14, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 20, 2026	March 19, 2026	2026	View Filing
10-Q 10-Q 2025 Q4 Q4	February 05, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 05, 2026	February 05, 2026	2026	View Filing
10-Q 10-Q 2025 Q3 Q3	November 06, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 06, 2025	November 06, 2025	2025	View Filing
10-Q 10-Q 2025 Q2 Q2	August 07, 2025	June 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	August 07, 2025	August 07, 2025	2025	View Filing
DEF 14A DEF 14A 2025 N/A	June 27, 2025	August 05, 2025	2025	View Filing

Showing 1 to 10 of 325 filings

Related Guides

Blog Categories

Continue your PBH research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.